Kymera Therapeutics, Inc. ( KYMR) - Key Metrics
KYMR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.66 | -$0.62 | -$0.55 | -$0.56 |
| 2026Q1 | $0.35 | -$0.71 | -$0.91 | -$0.92 |
| 2025Q4 | $0.03 | -$1.03 | -$0.79 | -$0.79 |
| 2025Q3 | $0.03 | -$0.94 | -$0.31 | -$0.31 |
| 2025Q2 | $0.14 | -$0.95 | -$0.74 | -$0.75 |
KYMR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -46.24 |
| 2026Q1 | 0% | -29.33 |
| 2025Q4 | 0% | -19.85 |
| 2025Q3 | 0% | -15.05 |
| 2025Q2 | 0% | -11.48 |
KYMR
Price: $106.02
52 week price:
Earnings Per Share: -3.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 492600
Market Capitalization: 8.8 billion